Following roll-out of HLP, commissioner and contractor/employer views were sought. The results show that commissioners value and understand the potential of HLPs, and that the overall effect of HLP implementation was positive for all types of contractors/employers PLX4032 and their employees. The
HLP approach is a tiered commissioning framework aimed at achieving consistent delivery of a broad range of high quality services through community pharmacies to meet local need, improving the health and wellbeing of the local population and helping to reduce health inequalities. Following positive evaluation of the Portsmouth HLP in 2009/10, a roll-out programme was created to support HLP implementation
in 20 pathfinder areas across England with the aim of evaluating against five objectives, one of which was ‘What are the benefits of HLP implementation for the commissioner, contractor and employer?’. Assessing this is important as the success of the programme depends on acceptance by all stakeholders, each of whom has different criteria Maraviroc concentration for success. Commissioners’ views were qualitatively analysed from the free text parts of 14 pathfinder area reports using thematic analysis. A short online survey was developed to quantitatively assess the benefits (both real and perceived) of HLP implementation for contractors/employers. Farnesyltransferase Pathfinder leads disseminated the survey link to their individual HLPs in September 2012 and survey completion was incentivised with a random draw for a Health Champion training distance or e-learning course. NRES guidance
deemed this to be service evaluation and therefore ethical approval was not required. Commissioner views (n = 14): Qualitative analysis identified the following themes: Commissioners viewed HLPs as an important delivery mechanism for public health services, using the quality mark as a proven track record for service delivery. HLP has acted as a catalyst to help develop and improve working relationships between commissioners and providers. Services have been commissioned or further extended as a result of pharmacies having HLP status, demonstrating that commissioners have confidence in the outcomes of services. HLP quality markers should be nationally accredited to avoid local variation, enable training opportunities and to embed it as part of the NHS. Contractor/Employer survey: 153 surveys were returned, a response rate of 38%. The table shows the proportion(%) of pharmacies who observed an increase, no difference or decrease in specific metrics as a result of becoming an HLP. Proportion(%) who observed: Increase No difference Decrease Pharmacy income 43.1 54.9 1.3 Prescription volume 32.7 60.8 6.5 Service activity 61.8 37.5 0.